NewsRamp Science, Exploration and Discovery Podcast
TransCode Therapeutics Advances TTX-MC138 for Glioblastoma
Jan 6, 2026
2:13
-(0)
About this episode
TransCode Therapeutics' preclinical research on TTX-MC138 for glioblastoma demonstrates increased tumor cell apoptosis and improved survival, showcasing the potential of their TTX delivery platform. Additionally, McEwen Inc. completes a business combination with Canadian Gold Corp., acquiring the company and gaining full ownership of the Tartan project.
Comments
Rate this episode
Episode Details
- Author
- NewsRamp
- Show Type
- full
- Audio Format
- audio/mpeg